Abstract PS4-07-06: Independent validation of TNBCDX, a 15-gene genomic risk stratification tool for early-stage triple-negative breast cancer
F. Brasó-Maristany(Breast Cancer Research Foundation), M. Alva(Research Institute Hospital 12 de Octubre), Isabel García-Fructuoso(Breast Cancer Research Foundation), M. Vidal(Hospital Clínic de Barcelona), Laura Lema(Hospital Universitario 12 De Octubre), M. Rey(Breast Cancer Research Foundation), E Seguí(Hospital Clínic de Barcelona), A. Prat(Cancer Clinic), B. Adamo(Hospital Clínic de Barcelona), Gisela Riu(Hospital Clínic de Barcelona), L. Pare(Oryzon Genomics (Spain)), F. Pardo(Oryzon Genomics (Spain)), M. Muñoz(Hospital Clínic de Barcelona), R. Gómez-Bravo(Hospital Clínic de Barcelona), J. Montes(Research Institute Hospital 12 de Octubre), F. Schettini(Hospital Clínic de Barcelona), M. Cobos(Research Institute Hospital 12 de Octubre), L. Parilla(Research Institute Hospital 12 de Octubre), M. Bergamino(Hospital Clínic de Barcelona), A. Madariaga(Research Institute Hospital 12 de Octubre), L. Manso(Research Institute Hospital 12 de Octubre), M. Marín-Aguilera(Oryzon Genomics (Spain)), P. Tolosa(Research Institute Hospital 12 de Octubre), T. Pascual(Hospital Clínic de Barcelona), E. Ciruelos(Research Institute Hospital 12 de Octubre), P. Galván(Breast Cancer Research Foundation), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), R. Moreno(Research Institute Hospital 12 de Octubre), Paula Blasco(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 0
Related Papers
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
|Cancer Discovery|2020|183
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
|British Journal of Cancer|2017|106
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
|JAMA Oncology|2024|77
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
|Nature Communications|2023|65
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry
|European Journal of Surgical Oncology|2018|60